Literature DB >> 27957035

Atrial Fibrillation and Its Association with Endocrine Disorders.

Manjari Devidi1, Avanija Buddam2, Sunil Dacha1, D Sudhaker Rao3.   

Abstract

Atrial Fibrillation (AF) is the most common arrhythmia affecting millions of people and the number is rising, it is therefore important to understand the risk factors causing AF. Risk factors such as hypertension, heart failure, coronary heart disease, and type 2 diabetes mellitus increase the risk of AF, however, the underlying etiology in a majority of patients remains elusive. Many of the endocrine disorders have been implicated in causing AF and an in depth knowledge of these disorders helps in early diagnosis and treatment. Due to the high prevalence of AF and its complications, it is therefore important to recognize these risk factors and have a low threshold for suspicion while other common causes are being excluded. In this review we summarize the issues related to AF and endocrine disorders. A better understanding of the relationship may lead to the development of the primary preventive strategies, fostering a more preventive and predictive approach that may result in decreased incidence of AF and its associated complications and provide personalized treatment options. For this review we carried out a search of Pubmed, the words or combination of words we used for our search include Endocrine disorders, metabolic disorders, Dyslipidemia, Diabetes mellitus type 2, Vitamin D, Hyperthyroidism, Primary aldosteronism, Pheochromocytoma, Obesity, Hypercalcemia, Hypogonadism, Medications, and Atrial fibrillation. We also retrieved articles from the references of retrieved articles.

Entities:  

Year:  2014        PMID: 27957035      PMCID: PMC4956123          DOI: 10.4022/jafib.959

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  79 in total

1.  Corticosteroids and the risk of atrial fibrillation.

Authors:  Cornelis S van der Hooft; Jan Heeringa; Guy G Brusselle; Albert Hofman; Jacqueline C M Witteman; J Herre Kingma; Miriam C J M Sturkenboom; Bruno H Ch Stricker
Journal:  Arch Intern Med       Date:  2006-05-08

2.  Lipoprotein(a) and lipid profile in patients with atrial fibrillation.

Authors:  José Antonio Díaz-Peromingo; Ana Albán-Salgado; Florinda García-Suárez; Joaquín Sánchez-Leira; Juan Saborido-Froján; Marina Iglesias-Gallego
Journal:  Med Sci Monit       Date:  2006-02-23

Review 3.  Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies.

Authors:  Arthur R Menezes; Carl J Lavie; James J DiNicolantonio; James O'Keefe; Daniel P Morin; Sammy Khatib; Richard V Milani
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

4.  Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.

Authors:  Marco V Perez; Paul J Wang; Joseph C Larson; Beth A Virnig; Barbara Cochrane; J David Curb; Liviu Klein; JoAnn E Manson; Lisa W Martin; Jennifer Robinson; Sylvia Wassertheil-Smoller; Marcia L Stefanick
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-11-20

Review 5.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

6.  Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus.

Authors:  Jun Gu; Xu Liu; Xinhua Wang; Haifeng Shi; Hongwei Tan; Li Zhou; Jianing Gu; Weifeng Jiang; Yuanlong Wang
Journal:  Europace       Date:  2011-05-07       Impact factor: 5.214

7.  Design of the Fracture Intervention Trial.

Authors:  D M Black; T F Reiss; M C Nevitt; J Cauley; D Karpf; S R Cummings
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

8.  The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

Authors:  Chris J Malkin; Peter J Pugh; Richard D Jones; Dheeraj Kapoor; Kevin S Channer; T Hugh Jones
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

9.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

Review 10.  Natural history, diagnosis and management of subclinical thyroid dysfunction.

Authors:  Bernadette Biondi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.